Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
E.Merge Technology Acquisition Corp. (ETAC) Prices 52.2M Units IPO at $10/Unit
-
PropTech Acquisition Corporation to Combine with Porch.com, Bringing a Leading Vertical Software and Services Platform for the Home to the Public Market
-
PropTech Acquisition Corporation to Combine with Porch.com, Bringing a Leading Vertical Software and Services Platform for the Home to the Public Market
-
E.Merge Technology Acquisition Corp. Announces Pricing of $522,000,000 Initial Public Offering
-
E.Merge Technology Acquisition Corp. Announces Pricing of $522,000,000 Initial Public Offering
-
Orchid Island Capital Announces Second Quarter 2020 Results
-
Spectrum Pharma (SPPI) Prices 21.67M Share Common Offering at $3/Sh
-
uniQure Announces Second Quarter 2020 Financial Results and Highlights Recent Company Progress
-
Spectrum Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Companies with NDRs 7/30
-
Spectrum Pharma (SPPI) Announces Proposed Public Offering of Common Stock
-
Spectrum Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
SOC Telemed to Merge with Healthcare Merger Corp.
-
Alkermes (ALKS) PT Raised to $20 at Cantor Fitzgerald
-
Companies with NDRs 7/29
-
Kindred Biosciences (KIN) PT Lowered to $11 at Cantor Fitzgerald
-
Companies with NDRs 7/28
-
PolarityTE (PTE) DFU Results are Highly Compelling, Cantor Fitzgerald Reiterates Overweight
-
ACE Convergence Acquisition Corp. (ACEV) Prices 20M Unit IPO at $10/Unit
-
ACE Convergence Acquisition Corp. Announces Pricing of $200,000,000 Initial Public Offering
-
UPDATE: Cantor Fitzgerald Starts I-Mab (IMAB) at Overweight
-
The Lupus Research Alliance Launches the ManyOne Can. Walk with Us to Cure Lupus Virtual Experience to Support Lupus Research
-
Caledonia Mining Corporation Plc: Block Listing Application and "At The Market" Sales Agreement
-
Caledonia Mining Corporation Plc: Block Listing Application and "At The Market" Sales Agreement
-
Cantor Fitzgerald Said 'Just the Beginning' of CymaBay Therapeutic (CBAY) Share Recovery After FDA Hold Lifted
-
Cantor Fitzgerald Reiterates Overweight Rating on Pfizer (PFE)
-
ALX Oncology Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
ALX Oncology Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Freddie Mac Prices $828 Million Multifamily K-Deal, K-F81
-
OrganiGram Holdings Inc (OGI:CN) (OGI) PT Lowered to Cdn$5 at Cantor Fitzgerald, Following Earnings
-
Buy Emergent BioSolutions (EBS) on Index Rebalancing Weakness - Cantor Fitzgerald
-
Molecular Templates (MTEM) Raises $43 Million in Gross Proceeds Through Its At-the-Market Facility
-
Molecular Templates, Inc. Raises $43 Million in Gross Proceeds Through Its At-the-Market Facility
-
A Better Financial Plan, LLC., Announces Settlement With The Securities And Exchange Commission After Three-Year Investigation
-
Evolent Health (EVH) PT Raised to $10 at Cantor Fitzgerald on Asset Sale
-
Companies with NDRs 7/17
-
UPDATE: Cantor Fitzgerald Starts Curis (CRIS) at Overweight
-
Cytokinetics (CYTK) Prices 7.29M Share Common Offering at $24/Sh
-
ALX Oncology Holdings Inc. (ALXO) Prices 8.5M Share IPO at $19/Sh
-
Cytokinetics Announces Pricing of Public Offering of Common Stock
-
ALX Oncology Announces Pricing of Initial Public Offering
-
ALX Oncology Announces Pricing of Initial Public Offering
-
Emergent BioSolutions (EBS) PT Raised to $110 at Cantor Fitzgerald
-
Companies with NDRs 7/16
-
Orchid Island Capital Announces Estimated Second Quarter 2020 Results, July 2020 Monthly Dividend and June 30, 2020 RMBS Portfolio Characteristics
-
Cytokinetics (CYTK) Announces Proposed $150M Share Common Offering
-
Cytokinetics Announces Proposed Public Offering of Common Stock
-
UnitedHealth Group (UNH) PT Raised to $350 at Cantor Fitzgerald, Following Earnings
-
Aphria Inc. (APHA:CN) (APHA) PT Raised to Cdn$10.50 at Cantor Fitzgerald


